Skip to main content

Peer Review reports

From: Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study

Original Submission
21 Sep 2021 Submitted Original manuscript
22 Oct 2021 Reviewed Reviewer Report - Arindam Pramanik
28 Oct 2021 Reviewed Reviewer Report
16 Nov 2021 Author responded Author comments - Zhichao Tian
Resubmission - Version 2
16 Nov 2021 Submitted Manuscript version 2
29 Nov 2021 Author responded Author comments - Zhichao Tian
Resubmission - Version 3
29 Nov 2021 Submitted Manuscript version 3
6 Dec 2021 Author responded Author comments - Zhichao Tian
Resubmission - Version 4
6 Dec 2021 Submitted Manuscript version 4
14 Dec 2021 Author responded Author comments - Zhichao Tian
Resubmission - Version 5
14 Dec 2021 Submitted Manuscript version 5
1 Jan 2022 Reviewed Reviewer Report - Arindam Pramanik
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
5 Jan 2022 Editorially accepted
12 Jan 2022 Article published 10.1186/s12885-022-09176-1

You can find further information about peer review here.

Back to article page